Core Lab (CLB)
Analyzes reservoir rocks and fluids while supplying completion diagnostics and perforating systems.
BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB
BlackRock Inc. acquired a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,460,118 shares of the oil and gas company's stock, valued at approximately $86,910,000. BlackRock Inc. owned 16.26% of Core Laboratories
Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Advisors Capital Management LLC Makes New $2.77 Million Investment in Core Laboratories Inc. $CLB
Advisors Capital Management LLC purchased a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 237,398 shares of the oil and gas company's stock, valued at approximately $2,766,000. Advisors Capital Management LLC owned 0.52% of Core
John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value
On June 30, 2026, John Rogers (Trades, Portfolio), founder of Ariel Investment, LLC, increased the firm's stake in Core Laboratories Inc (NYSE: CLB) by 904,557 s
Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?
Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.
Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y
CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.
Core Laboratories Q2 Earnings Call Highlights
Core Laboratories NYSE: CLB reported second-quarter 2026 revenue of $124.6 million, up more than 2% from the prior quarter but down 4% from a year earlier, as stronger completion-product sales partly offset disruptions to its service business from conflicts in the Middle East and Russia-Ukraine.
Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q2 2026 Earnings Call Transcript
Core Laboratories (CLB) Q2 Earnings Surpass Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.19 per share a year ago.
What's in Store for Core Laboratories Stock in Q2 Earnings?
CLB's Q2 may reflect resilient international activity and tariff insulation, but weaker reservoir description results and higher costs could weigh.
Earnings Preview: Core Laboratories (CLB) Q2 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Core Stock Down 39% in 6 Months: Should You Hold or Sell Now?
CLB struggles with ongoing headwinds from lower completion activity, operational disruptions, inflationary costs, weaker margins and projected earnings decline in 2026.
CORE LABORATORIES ANNOUNCES TIMING OF SECOND QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL
HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m.
Core Lab Stock Plunges 18% in 3 Months: Time to Hold or Fold?
CLB faces persistent geopolitical uncertainty, weaker laboratory activity, cost inflation and delayed shipments, limiting visibility into a stronger recovery.
Core Laboratories (CLB) Down 4.9% Since Last Earnings Report: Can It Rebound?
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?
Implied Volatility Surging for Core Laboratories Stock Options
Investors need to pay close attention to CLB stock based on the movements in the options market lately.
Core Laboratories Q1 Earnings Meet Estimates, Decline Y/Y
CLB's Q1 earnings meet estimates but fall Y/Y as a revenue miss and Middle East disruptions weigh on both key segments.
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Core Laboratories Inc. (CLB) Q1 2026 Earnings Call Transcript
Core Laboratories to Post Q1 Earnings: Key Metrics to Watch
CLB heads into Q1 earnings with lowered guidance, geopolitical disruptions and cost pressures raising concerns over a potential earnings miss.
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.